Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;22(3):214-217.
doi: 10.7861/clinmed.2022-0146.

Thrombocytopenia: the good, the bad and the ugly

Affiliations

Thrombocytopenia: the good, the bad and the ugly

Iona Ashworth et al. Clin Med (Lond). 2022 May.

Abstract

New thrombocytopenia may be associated with a variety of conditions and diagnosis can be challenging. Presentation can vary from life-threatening bleeding or thrombosis to an incidental finding in an asymptomatic patient. New thrombocytopenia requires urgent investigation. Investigations are mainly guided by findings from the clinical history, physical examination, full blood count and blood film analysis. Aside from the actively bleeding patient, rare but life-threatening causes of thrombocytopenia must be identified early as they require urgent treatment. These include thrombotic thrombocytopenic purpura, disseminated intravascular coagulation, suspicion of new acute promyelocytic leukaemia, and vaccine-induced prothrombotic immune thrombocytopenia. Here, we discuss how to approach a patient with new thrombocytopenia, along with key differentials not to be missed.

Keywords: bleeding; haematology; platelets; thrombocytopenia; thrombosis.

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Blood films. a) Red cell fragmentation obtained from a patient presenting with renal failure and confusion secondary to thrombotic thrombocytopenic purpura. b) Thrombocytopenia and features of disseminated intravascular coagulation obtained from a patient presenting with bleeding secondary to acute promyelocytic leukaemia.

Similar articles

Cited by

References

    1. Stasi R. How to approach thrombocytopenia. Hematology Am Soc Hematol Educ Program 2012;2012:191–7. - PubMed
    1. Gernsheimer T, James AH, Stasi R. How I treat thrombocytopenia in pregnancy. Blood J Am Soc Hematol 2013;121:38–47. - PubMed
    1. Provan D, Stasi R, Newland A, et al. . International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115:168–86. - PubMed
    1. Estcourt L, Birchall J, Allard S, et al. Guidelines for the use of platelet transfusions. 2016;176:365–94. - PubMed
    1. Scully M, Hunt BJ, Benjamin S, et al. . Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 2012;158:323–35. - PubMed

MeSH terms